RaySearch Laboratories AB (publ) (RAY-B.ST)
SEK 205.0
(1.49%)
SEK 205.0
(1.49%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 81.57 Million SEK | 243.06% |
| 2022 | 23.77 Million SEK | 150.25% |
| 2021 | -47.31 Million SEK | -421.09% |
| 2020 | -9.08 Million SEK | -118.01% |
| 2019 | 50.41 Million SEK | -35.8% |
| 2018 | 78.52 Million SEK | -33.24% |
| 2017 | 117.62 Million SEK | -22.31% |
| 2016 | 151.4 Million SEK | 115.65% |
| 2015 | 70.2 Million SEK | 17.34% |
| 2014 | 59.83 Million SEK | 387.09% |
| 2013 | -20.84 Million SEK | -204.92% |
| 2012 | 19.86 Million SEK | 16.79% |
| 2011 | 17 Million SEK | -41.14% |
| 2010 | 28.89 Million SEK | -4.15% |
| 2009 | 30.14 Million SEK | 65.43% |
| 2008 | 18.22 Million SEK | -7.87% |
| 2007 | 19.77 Million SEK | -45.39% |
| 2006 | 36.21 Million SEK | 24.28% |
| 2005 | 29.14 Million SEK | 125.85% |
| 2004 | 12.9 Million SEK | 356.88% |
| 2003 | -5.02 Million SEK | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 61.43 Million SEK | 67.4% |
| 2024 Q1 | 36.69 Million SEK | 16.35% |
| 2023 FY | 81.57 Million SEK | 243.06% |
| 2023 Q3 | 21.55 Million SEK | 97.39% |
| 2023 Q2 | 10.91 Million SEK | -37.84% |
| 2023 Q1 | 17.56 Million SEK | 24.23% |
| 2023 Q4 | 31.54 Million SEK | 46.35% |
| 2022 Q4 | 14.13 Million SEK | 40.36% |
| 2022 Q2 | -19.73 Million SEK | -202.24% |
| 2022 Q1 | 19.29 Million SEK | 220.85% |
| 2022 FY | 23.77 Million SEK | 150.25% |
| 2022 Q3 | 10.07 Million SEK | 151.05% |
| 2021 Q3 | -21.99 Million SEK | -33.54% |
| 2021 FY | -47.31 Million SEK | -421.09% |
| 2021 Q1 | 7.11 Million SEK | 150.2% |
| 2021 Q4 | -15.96 Million SEK | 27.39% |
| 2021 Q2 | -16.46 Million SEK | -331.6% |
| 2020 Q2 | -9.19 Million SEK | -122.73% |
| 2020 Q1 | 40.46 Million SEK | 113.67% |
| 2020 Q4 | -14.16 Million SEK | 45.9% |
| 2020 FY | -9.08 Million SEK | -118.01% |
| 2020 Q3 | -26.18 Million SEK | -184.71% |
| 2019 Q3 | -7.52 Million SEK | -134.47% |
| 2019 Q2 | 21.83 Million SEK | 27.19% |
| 2019 Q4 | 18.93 Million SEK | 351.65% |
| 2019 FY | 50.41 Million SEK | -35.8% |
| 2019 Q1 | 17.16 Million SEK | -47.42% |
| 2018 FY | 78.52 Million SEK | -33.24% |
| 2018 Q4 | 32.64 Million SEK | 141.84% |
| 2018 Q3 | 13.5 Million SEK | -34.45% |
| 2018 Q2 | 20.59 Million SEK | 74.85% |
| 2018 Q1 | 11.77 Million SEK | -83.71% |
| 2017 FY | 117.62 Million SEK | -22.31% |
| 2017 Q1 | 26.27 Million SEK | -65.39% |
| 2017 Q3 | -1.02 Million SEK | -105.12% |
| 2017 Q2 | 20.09 Million SEK | -23.53% |
| 2017 Q4 | 72.28 Million SEK | 7132.0% |
| 2016 Q1 | 17.76 Million SEK | -46.68% |
| 2016 FY | 151.4 Million SEK | 115.65% |
| 2016 Q2 | 28.83 Million SEK | 62.37% |
| 2016 Q3 | 28.88 Million SEK | 0.17% |
| 2016 Q4 | 75.92 Million SEK | 162.83% |
| 2015 FY | 70.2 Million SEK | 17.34% |
| 2015 Q3 | 14.48 Million SEK | 655.85% |
| 2015 Q4 | 33.31 Million SEK | 130.05% |
| 2015 Q2 | -2.6 Million SEK | -110.41% |
| 2015 Q1 | 25.02 Million SEK | -38.51% |
| 2014 Q2 | 1000.00 SEK | -99.98% |
| 2014 FY | 59.83 Million SEK | 387.09% |
| 2014 Q4 | 40.69 Million SEK | 208.28% |
| 2014 Q3 | 13.2 Million SEK | 1320000.0% |
| 2014 Q1 | 5.93 Million SEK | 16.51% |
| 2013 Q4 | 5.09 Million SEK | 133.71% |
| 2013 FY | -20.84 Million SEK | -204.92% |
| 2013 Q3 | -15.1 Million SEK | 5.56% |
| 2013 Q2 | -15.99 Million SEK | -409.22% |
| 2013 Q1 | 5.17 Million SEK | -79.6% |
| 2012 Q1 | 4.61 Million SEK | -32.03% |
| 2012 Q3 | -1.46 Million SEK | 83.08% |
| 2012 Q2 | -8.65 Million SEK | -287.44% |
| 2012 FY | 19.86 Million SEK | 16.79% |
| 2012 Q4 | 25.36 Million SEK | 1832.51% |
| 2011 Q2 | -332 Thousand SEK | -120.79% |
| 2011 Q3 | 8.94 Million SEK | 2795.48% |
| 2011 Q4 | 6.79 Million SEK | -24.09% |
| 2011 FY | 17 Million SEK | -41.14% |
| 2011 Q1 | 1.59 Million SEK | -85.93% |
| 2010 Q4 | 11.35 Million SEK | 5971.66% |
| 2010 FY | 28.89 Million SEK | -4.15% |
| 2010 Q3 | 187 Thousand SEK | -97.95% |
| 2010 Q2 | 9.12 Million SEK | 10.76% |
| 2010 Q1 | 8.23 Million SEK | -53.02% |
| 2009 Q1 | 7.32 Million SEK | 0.0% |
| 2009 Q3 | 316 Thousand SEK | -93.66% |
| 2009 FY | 30.14 Million SEK | 65.43% |
| 2009 Q4 | 17.52 Million SEK | 5446.2% |
| 2009 Q2 | 4.98 Million SEK | -31.98% |
| 2008 FY | 18.22 Million SEK | -7.87% |
| 2007 FY | 19.77 Million SEK | -45.39% |
| 2006 FY | 36.21 Million SEK | 24.28% |
| 2005 FY | 29.14 Million SEK | 125.85% |
| 2004 FY | 12.9 Million SEK | 356.88% |
| 2003 FY | -5.02 Million SEK | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Aino Health AB (publ) | -10.66 Million SEK | 865.144% |
| Bonzun AB (publ) | 13.88 Million SEK | -487.509% |
| Kontigo Care AB (publ) | 212 Thousand SEK | -38377.358% |
| Medhelp Care Aktiebolag (publ) | -11.01 Million SEK | 840.89% |
| Surgical Science Sweden AB (publ) | 233.97 Million SEK | 65.136% |